Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders
Clinical trial NCT01288716 · COMPLETED
Trial details
- NCT number
- NCT01288716
- Sponsor
- Seaside Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-08-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.